Krzysztof Lewandowski Agata Kopydłowska Zuzanna Kanduła Bartłomiej Sankowski Marcin Machnicki Marta Barańska Kinga Gwóźdź-Bąk Tadeusz Kubicki Anna Płotka Łucja Przysiecka Grzegorz Dworacki Piotr Kozłowski Tomasz Stokłosa
10.1111/jcmm.17647
J Cell Mol Med
2023 Jan;27(2):299-303.
calr hras essential thrombocythemia multiple myeloma
CC BY
https://pubmed.ncbi.nlm.nih.gov/36606310/
Multiple Myeloma / complications Multiple Myeloma / genetics Myeloproliferative Disorders / genetics Thrombocythemia, Essential / complications Thrombocythemia, Essential / diagnosis Thrombocythemia, Essential / genetics
Multiple Myeloma / complications Multiple Myeloma / genetics Myeloproliferative Disorders / genetics Thrombocythemia, Essential / complications Thrombocythemia, Essential / diagnosis Thrombocythemia, Essential / genetics Case Reports Research Support, Non-U.S. Gov't Calreticulin / genetics Calreticulin / metabolism Genomic Instability Humans Janus Kinase 2 / metabolism Middle Aged Mutation / genetics Proto-Oncogene Proteins p21(ras) / genetics Janus Kinase 2 Calreticulin HRAS protein, human Proto-Oncogene Proteins p21(ras)
PMC9843526
36606310
HRAS mutation positive multiple myeloma in the type 2 CALR mutation positive essential thrombocythemia: A case report
2023